Abstract:Abstract Background Acute respiratory distress syndrome (ARDS) is a heterogeneous syndrome, and the identification of homogeneous subgroups and phenotypes is the first step toward precision critical care. We aimed to explore whether ARDS phenotypes can be identified using clinical data, are reproducible and are associated with clinical outcomes and treatment response. Methods This study is based on a retrospective analysis of data from the telehealth intensive care unit (eICU) collaborative research database and three ARDS randomized controlled trials (RCTs) (ALVEOLI, FACTT and SAILS trials). We derived phenotypes in the eICU by cluster analysis based on clinical data and compared the clinical characteristics and outcomes of each phenotype. The reproducibility of the derived phenotypes was tested using the data from three RCTs, and treatment effects were evaluated. Results Three clinical phenotypes were identified in the training cohort of 3875 ARDS patients. Of the three phenotypes identified, phenotype I ( n = 1565; 40%) was associated with fewer laboratory abnormalities, less organ dysfunction and the lowest in-hospital mortality rate (8%). Phenotype II ( n = 1232; 32%) was correlated with more inflammation and shock and had a higher mortality rate (18%). Phenotype III ( n = 1078; 28%) was strongly correlated with renal dysfunction and acidosis and had the highest mortality rate (22%). These results were validated using the data from the validation cohort ( n = 3670) and three RCTs ( n = 2289) and had reproducibility. Patients with these ARDS phenotypes had different treatment responses to randomized interventions. Specifically, in the ALVEOLI cohort, the effects of ventilation strategy (high PEEP vs low PEEP) on ventilator-free days differed by phenotype ( p = 0.001); in the FACTT cohort, there was a significant interaction between phenotype and fluid-management strategy for 60-day mortality ( p = 0.01). The fluid-conservative strategy was associated with improved mortality in phenotype II but had the opposite effect in phenotype III. Conclusion Three clinical phenotypes of ARDS were identified and had different clinical characteristics and outcomes. The analysis shows evidence of a phenotype-specific treatment benefit in the ALVEOLI and FACTT trials. These findings may improve the identification of distinct subsets of ARDS patients for exploration in future RCTs.

Identification of genetic profile and biomarkers involved in acute respiratory distress syndrome

Mir-584 and Mir-146 Are Candidate Biomarkers for Acute Respiratory Distress Syndrome

Novel Biomarkers for Acute Respiratory Distress Syndrome: Genetics, Epigenetics and Transcriptomics

Integrative omics provide biological and clinical insights into acute respiratory distress syndrome

Targeted Sequencing Of Top Loci Identified By Genome-Wide Association Study (GWAS) Associated With Acute Respiratory Distress Syndrome (ARDS)

Identifying risk factors for acute respiratory distress syndrome in critically ill patients: a retrospective study

Prediction Model for Critically Ill Patients with Acute Respiratory Distress Syndrome

Causal relationship between lipidome and acute respiratory distress syndrome

Integrative multi-omics analysis unravels the host response landscape and reveals a serum protein panel for early prognosis prediction for ARDS

The genomic landscape of Acute Respiratory Distress Syndrome: a meta-analysis by information content of genome-wide studies of the host response

Disease-specific dynamic biomarkers selected by integrating inflammatory mediators with clinical informatics in ARDS patients with severe pneumonia

Genetic Determinants of the Acute Respiratory Distress Syndrome

Identification of Three Classes of Acute Respiratory Distress Syndrome Using Latent Class Analysis

Analytics with Artificial Intelligence to Advance the Treatment of Acute Respiratory Distress Syndrome

Development of genomic phenotype and immunophenotype of acute respiratory distress syndrome using autophagy and metabolism-related genes

Predictive model for acute respiratory distress syndrome events in ICU patients in China using machine learning algorithms: a secondary analysis of a cohort study

Identification of distinct clinical phenotypes of acute respiratory distress syndrome with differential responses to treatment

Integrative proteomic profiling of lung tissues and blood in acute respiratory distress syndrome

Potential diagnostic biomarkers and Mapk14 protein expression: Autophagy-related genes linking immune infiltration in acute respiratory distress syndrome

A modified acute respiratory distress syndrome prediction score: a multicenter cohort study in China.

Nucleotide polymorphism in ARDS outcome: a whole exome sequencing association study